At Median Technologies, we apply our clinical expertise, proprietary technologies and mastery of data science to generate valuable insights from medical images for oncology drug development and patient care.
Our iCRO image analysis and management solutions help biopharma companies drive their oncology clinical studies toward successful approval and enhance their decision making through innovative biomarker development and additional signal extraction from images.
With iBiopsy®, our AI-powered imaging platform for the development of software as medical device (SaMD), we enable clinicians to diagnose patients earlier and monitor diseases throughout the patient journey.
In the United States, Median is a leading provider of oncology clinical trial imaging solutions, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational rigor and reliability. In addition, we are pioneers in innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop bespoke insights for biopharmaceutical companies worldwide through our specialized Imaging Lab solutions.
We have joined MassBio to continue building strong relationships within the life sciences network in Massachusetts and beyond. By collaborating with industry peers and engaging in, we hope to learn from the community, add value to important discussions, and connect with researchers to further the insights we can extract from images.To learn more about us, visit our website at mediantechnologies.com.